Stephen D. Hauschka
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Skeletal muscleGoogle:
"Stephen Hauschka"Parents
Sign in to add mentor| Mark R. Adelman | grad student | University of Washington | |
| Irwin R. Konigsberg | post-doc | Johns Hopkins |
Children
Sign in to add trainee| Jeffrey Chamberlain | grad student | University of Washington (Cell & Gene Therapy Tree) | |
| Julie C. Kiefer | grad student | 2001 | University of Washington |
| Maja Z. Salva | grad student | 2006 | University of Washington |
| Alicia M. Baranski | grad student | 2007 | University of Washington |
| Richard L Frock | grad student | 2002-2009 | UW Medical School |
| Phillip Tai | grad student | 2010 | University of Washington |
| J. Chloë Bulinski | post-doc | University of Washington | |
| Bradley B. Olwin | post-doc | University of Washington (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tasfaout H, Halbert CL, McMillen TS, et al. (2024) Split intein-mediated protein trans-splicing to express large dystrophins. Nature |
| Karbassi E, Padgett R, Bertero A, et al. (2024) Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium. Cellular and Molecular Life Sciences : Cmls. 81: 95 |
| Birch SM, Lawlor MW, Conlon TJ, et al. (2023) Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Science Translational Medicine. 15: eabo1815 |
| Bengtsson NE, Crudele JM, Klaiman JM, et al. (2022) Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Bengtsson NE, Tasfaout H, Hauschka SD, et al. (2020) Dystrophin gene editing stability is dependent on dystrophin levels in skeletal but not cardiac muscles. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Kwon JB, Ettyreddy AR, Vankara A, et al. (2020) Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy. Molecular Therapy. Methods & Clinical Development. 19: 320-329 |
| Kolwicz SC, Hall JK, Moussavi-Harami F, et al. (2019) Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate. Jacc. Basic to Translational Science. 4: 778-791 |
| Ramos JN, Hollinger K, Bengtsson NE, et al. (2019) Development of Novel Micro-dystrophins with Enhanced Functionality. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Tawara N, Yamashita S, Kawakami K, et al. (2018) Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions. Experimental Neurology |
| Murray J, Odom G, Olafsson S, et al. (2018) AAV-Mediated Delivery of Ribonucleotide Reductase and Microdystrophin Rescues Function in Dystrophic Mice Biophysical Journal. 114: 541a |